阿诺医药是一家临床阶段的全球性生物制药公司，致力于开发差异化、创新性的肿瘤免疫治疗药物，涵盖4款临床阶段及多款临床前候选药物。
Location: China, Zhejiang, Hangzhou City
Employees: 11-50
Total raised: $153M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | triwise | en.triwise... |
| - | Matrix Par... | matrixpart... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 13.07.2021 | Series D | $100M | - | fiercebiot... |
| 05.07.2018 | Series B | $53M | - | finsmes.co... |
Mentions in press and media 12
| Date | Title | Description | Source |
| 15.03.2022 | Adlai Nortye Announces Appointment of Dr. Victoria Demby as ... | NORTH BRUNSWICK, N.J. and HANGZHOU, China, March 15, 2022 /PRNewswire/ -- Adlai Nortye Ltd. ("A... | en.prnasia... |
| 21.02.2022 | Adlai Nortye Announces Publication of Preclinical Research o... | NORTH BRUNSWICK, N.J. and HANGZHOU, China, Feb. 21, 2022 /PRNewswire/ -- recently -- Adlai Nortye Lt... | en.prnasia... |
| 26.01.2022 | Adlai Nortye Announces Global License-out Agreement with Bio... | NORTH BRUNSWICK, N.J. and HANGZHOU, China, Jan. 26, 2022 /PRNewswire/ -- Adlai Nortye Ltd. ("Ad... | en.prnasia... |
| 06.01.2022 | Adlai Nortye Announces First Patient Dosed in Phase I Clinic... | NORTH BRUNSWICK, N.J. and HANGZHOU, China, Jan. 6, 2022 /PRNewswire/ -- Adlai Nortye Ltd. ("Adl... | en.prnasia... |
| 08.09.2021 | Adlai Nortye Announces First Patient Dosed in Phase Ia Clini... | NORTH BRUNSWICK, New Jersey and HANGZHOU, China, Sept. 8, 2021 /PRNewswire/ -- Adlai Nortye, a globa... | en.prnasia... |
| 15.07.2021 | China's Adlai Nortye nabs another cool $100M for its immuno-... | Adlai Nortye has added $100 million to the bank to fuel a phase 3 clinical trial of its lead program... | fiercebiot... |
| 15.07.2021 | China's Adlai Nortye nabs another cool $100M for its immuno-... | Adlai Nortye has added $100 million to the bank to fuel a phase 3 clinical trial of its lead program... | fiercebiot... |
| 13.07.2021 | Chinese biopharma firm Adlai Nortye bags $100m in a Series D... | Hangzhou Adlai Nortye Biopharma Co., Ltd, a Chinese clinical-stage biopharmaceutical firm that makes... | dealstreet... |
| 13.07.2021 | Chinese biopharma firm Adlai Nortye bags $100m in a Series D... | Premium Hangzhou Adlai Nortye Biopharma Co., Ltd, a Chinese clinical-stage biopharmaceutical firm t... | dealstreet... |
| 31.08.2020 | Chinese biopharma firm Adlai Nortye nets $100m in Series C r... | Premium Adlai Nortye, a China-based clinical-stage biopharmaceutical firm that develops immuno-onco... | dealstreet... |
Show more